Toms Capital Investment Management LP Viking Therapeutics, Inc. Transaction History
Toms Capital Investment Management LP
- $2.51 Billion
- Q2 2024
A detailed history of Toms Capital Investment Management LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Toms Capital Investment Management LP holds 763,600 shares of VKTX stock, worth $55.4 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
763,600Holding current value
$55.4 Million% of portfolio
1.61%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VKTX
# of Institutions
460Shares Held
65.6MCall Options Held
6.24MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$732 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$437 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$372 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$163 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$135 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.56B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...